Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Pollard

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|October 1, 2015
Biobanking for Personalized MedicineAngen Liu, Kai Pollard
Cancer Research|November 18, 2020
Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath TumorsJiawan Wang, Kai Pollard, Ana Calizo, et al.
Cancer Research|October 9, 2020
Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath TumorsJiawan Wang, Kai Pollard, Amy N Allen, et al.
Epigenetics & Chromatin|January 13, 2021
Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signalingJamie L Grit, Benjamin K Johnson, Patrick S Dischinger, et al.
Elife|March 4, 2022
Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasmaAustin K Mattox, Christopher Douville, Natalie Silliman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2023
MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath TumorsDana C Borcherding, Neha V Amin, Kevin He, et al.
Oncogene|April 23, 2022
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcomaPatience Odeniyide, Marielle E Yohe, Kai Pollard, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Science Advances|November 24, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Scientific Data|June 21, 2020
A clinically and genomically annotated nerve sheath tumor biospecimen repositoryKai Pollard, Jineta Banerjee, Xengie Doan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|October 1, 2015
Biobanking for Personalized MedicineAngen Liu, Kai Pollard
Cancer Research|November 18, 2020
Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath TumorsJiawan Wang, Kai Pollard, Ana Calizo, et al.
Cancer Research|October 9, 2020
Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath TumorsJiawan Wang, Kai Pollard, Amy N Allen, et al.
Epigenetics & Chromatin|January 13, 2021
Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signalingJamie L Grit, Benjamin K Johnson, Patrick S Dischinger, et al.
Elife|March 4, 2022
Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasmaAustin K Mattox, Christopher Douville, Natalie Silliman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2023
MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath TumorsDana C Borcherding, Neha V Amin, Kevin He, et al.
Oncogene|April 23, 2022
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcomaPatience Odeniyide, Marielle E Yohe, Kai Pollard, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Science Advances|November 24, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Scientific Data|June 21, 2020
A clinically and genomically annotated nerve sheath tumor biospecimen repositoryKai Pollard, Jineta Banerjee, Xengie Doan, et al.
Pageof 2